This is in contrast to a study showing that intrathecal shRNA-based silencing or pharmacological inhibition of TRPV1 leads to a reduction in myocardial infarct size in rats undergoing 30 min ischemia followed by 2 h reperfusion [39]. Here, TRPV1 is linked to myocardial infarction.